2023-507438-25-00CompletedPhase 1
Study which tests 3 medicines (SB27, EU sourced Keytruda, and US sourced Keytruda) in early or locally advanced non-small cell lung cancer patients who underwent surgery and adjuvant chemotherapy
Source: EU CTIS (euclinicaltrials.eu) · Last updated 28 Sept 2026
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 41 (actual)
- First submitted
- 22 Sept 2023
- Start date
- 28 Feb 2024
- Lead sponsor
- Samsung Bioepis Co. Ltd.
- Diseases
- Lung cancer
- EU CT number
- 2023-507438-25-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 41
- 6 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (6)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Universitario de Jaén | Jaén | Spain | Completed |
| Hospital Universitario Severo Ochoa | Leganés | Spain | Completed |
| Hospital Quironsalud Malaga | Málaga | Spain | Completed |
| Complexo Hospitalario Universitario De Santiago | Santiago de Compostela | Spain | Completed |
| Uniwersyteckie Centrum Kliniczne | Gdansk | Poland | Completed |
| Mazowieckie Centrum Leczenia Chorób Płuc i Gruźlicy | Otwock | Poland | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.